Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
EMBO J ; 35(8): 820-30, 2016 Apr 15.
Article in English | MEDLINE | ID: mdl-26873592

ABSTRACT

Voltage-gated sodium channels are essential for electrical signalling across cell membranes. They exhibit strong selectivities for sodium ions over other cations, enabling the finely tuned cascade of events associated with action potentials. This paper describes the ion permeability characteristics and the crystal structure of a prokaryotic sodium channel, showing for the first time the detailed locations of sodium ions in the selectivity filter of a sodium channel. Electrostatic calculations based on the structure are consistent with the relative cation permeability ratios (Na(+) ≈ Li(+) â‰« K(+), Ca(2+), Mg(2+)) measured for these channels. In an E178D selectivity filter mutant constructed to have altered ion selectivities, the sodium ion binding site nearest the extracellular side is missing. Unlike potassium ions in potassium channels, the sodium ions in these channels appear to be hydrated and are associated with side chains of the selectivity filter residues, rather than polypeptide backbones.


Subject(s)
Sodium Channels/chemistry , Sodium Channels/metabolism , Sodium/metabolism , Alphaproteobacteria/chemistry , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Binding Sites , Cations/metabolism , Crystallography, X-Ray , Glutamic Acid/genetics , HEK293 Cells , Humans , Ion Channel Gating , Models, Molecular , Mutation , Patch-Clamp Techniques , Permeability , Protein Conformation , Sodium Channels/genetics , Static Electricity
2.
Bioorg Med Chem Lett ; 28(19): 3255-3259, 2018 10 15.
Article in English | MEDLINE | ID: mdl-30143424

ABSTRACT

The oral S1PR1 agonist ponesimod demonstrated substantial efficacy in a phase II clinical trial of psoriasis. Unfortunately, systemic side effects were observed, which included lymphopenia and transient bradycardia. We sought to develop a topical soft-drug S1PR1 agonist with an improved therapeutic index. By modifying ponesimod, we discovered an ester series of S1PR agonists. To increase metabolic instability in plasma we synthesised esters described as specific substrates for paraoxonase and butyrylcholinesterases, esterases present in human plasma.


Subject(s)
Drug Discovery , Receptors, Lysosphingolipid/drug effects , Thiazoles/pharmacology , Administration, Topical , Aryldialkylphosphatase/blood , Chromatography, High Pressure Liquid , Chromatography, Reverse-Phase , Esterases/blood , Esterases/metabolism , Humans , Skin/enzymology , Solubility , Sphingosine-1-Phosphate Receptors , Structure-Activity Relationship , Thiazoles/administration & dosage
4.
J Biol Chem ; 291(19): 10210-27, 2016 May 06.
Article in English | MEDLINE | ID: mdl-26984406

ABSTRACT

This study investigated the effect of the biochemical and biophysical properties of the plasma membrane as well as membrane morphology on the susceptibility of human red blood cells to the cholesterol-dependent cytolysin pneumolysin, a key virulence factor of Streptococcus pneumoniae, using single cell studies. We show a correlation between the physical properties of the membrane (bending rigidity and surface and dipole electrostatic potentials) and the susceptibility of red blood cells to pneumolysin-induced hemolysis. We demonstrate that biochemical modifications of the membrane induced by oxidative stress, lipid scrambling, and artificial cell aging modulate the cell response to the toxin. We provide evidence that the diversity of response to pneumolysin in diabetic red blood cells correlates with levels of glycated hemoglobin and that the mechanical properties of the red blood cell plasma membrane are altered in diabetes. Finally, we show that diabetic red blood cells are more resistant to pneumolysin and the related toxin perfringolysin O relative to healthy red blood cells. Taken together, these studies indicate that the diversity of cell response to pneumolysin within a population of human red blood cells is influenced by the biophysical and biochemical status of the plasma membrane and the chemical and/or oxidative stress pre-history of the cell.


Subject(s)
Diabetes Mellitus/metabolism , Erythrocyte Membrane , Membrane Potentials/drug effects , Oxidative Stress/drug effects , Streptococcus pneumoniae/chemistry , Streptolysins/pharmacology , Bacterial Proteins/chemistry , Bacterial Proteins/pharmacology , Bacterial Toxins/chemistry , Bacterial Toxins/pharmacology , Erythrocyte Membrane/metabolism , Female , Hemolysin Proteins/chemistry , Hemolysin Proteins/pharmacology , Humans , Male , Streptolysins/chemistry
5.
Proc Natl Acad Sci U S A ; 111(23): 8428-33, 2014 Jun 10.
Article in English | MEDLINE | ID: mdl-24850863

ABSTRACT

Voltage-gated sodium channels are important targets for the development of pharmaceutical drugs, because mutations in different human sodium channel isoforms have causal relationships with a range of neurological and cardiovascular diseases. In this study, functional electrophysiological studies show that the prokaryotic sodium channel from Magnetococcus marinus (NavMs) binds and is inhibited by eukaryotic sodium channel blockers in a manner similar to the human Nav1.1 channel, despite millions of years of divergent evolution between the two types of channels. Crystal complexes of the NavMs pore with several brominated blocker compounds depict a common antagonist binding site in the cavity, adjacent to lipid-facing fenestrations proposed to be the portals for drug entry. In silico docking studies indicate the full extent of the blocker binding site, and electrophysiology studies of NavMs channels with mutations at adjacent residues validate the location. These results suggest that the NavMs channel can be a valuable tool for screening and rational design of human drugs.


Subject(s)
Alphaproteobacteria/metabolism , Bacterial Proteins/metabolism , NAV1.1 Voltage-Gated Sodium Channel/metabolism , Sodium Channels/metabolism , Alphaproteobacteria/chemistry , Alphaproteobacteria/genetics , Amino Acid Sequence , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Binding Sites/genetics , Crystallography, X-Ray , HEK293 Cells , Humans , Ion Channel Gating/drug effects , Ion Channel Gating/genetics , Ion Channel Gating/physiology , Lamotrigine , Membrane Potentials/drug effects , Membrane Potentials/physiology , Models, Molecular , Molecular Sequence Data , Mutation , NAV1.1 Voltage-Gated Sodium Channel/chemistry , NAV1.1 Voltage-Gated Sodium Channel/genetics , Protein Structure, Tertiary , Sequence Homology, Amino Acid , Sodium Channel Blockers/metabolism , Sodium Channel Blockers/pharmacology , Sodium Channels/chemistry , Sodium Channels/genetics , Triazines/metabolism , Triazines/pharmacology
6.
J Biol Chem ; 288(5): 3512-22, 2013 Feb 01.
Article in English | MEDLINE | ID: mdl-23239883

ABSTRACT

NetB is a pore-forming toxin produced by Clostridium perfringens and has been reported to play a major role in the pathogenesis of avian necrotic enteritis, a disease that has emerged due to the removal of antibiotics in animal feedstuffs. Here we present the crystal structure of the pore form of NetB solved to 3.9 Å. The heptameric assembly shares structural homology to the staphylococcal α-hemolysin. However, the rim domain, a region that is thought to interact with the target cell membrane, shows sequence and structural divergence leading to the alteration of a phosphocholine binding pocket found in the staphylococcal toxins. Consistent with the structure we show that NetB does not bind phosphocholine efficiently but instead interacts directly with cholesterol leading to enhanced oligomerization and pore formation. Finally we have identified conserved and non-conserved amino acid positions within the rim loops that significantly affect binding and toxicity of NetB. These findings present new insights into the mode of action of these pore-forming toxins, enabling the design of more effective control measures against necrotic enteritis and providing potential new tools to the field of bionanotechnology.


Subject(s)
Bacterial Toxins/chemistry , Bacterial Toxins/metabolism , Clostridium perfringens/metabolism , Animals , Bacterial Toxins/toxicity , Cell Line, Tumor , Cell Shape/drug effects , Chickens , Cholesterol/metabolism , Crystallography, X-Ray , Models, Molecular , Mutant Proteins/metabolism , Mutation/genetics , Phospholipids/metabolism , Protein Binding , Protein Multimerization/drug effects , Protein Structure, Tertiary , Solubility , Static Electricity
7.
BMC Chem ; 17(1): 91, 2023 Jul 27.
Article in English | MEDLINE | ID: mdl-37501200

ABSTRACT

The crystal structure of orthorhombic Bovine Pancreatic Ribonuclease A has been determined to 0.85 Å resolution using low temperature, 100 K, synchrotron X-ray data collected at 16000 keV (λ = 0.77 Å). This is the first ultra-high-resolution structure of a native form of Ribonuclease A to be reported. Refinement carried out with anisotropic displacement parameters, stereochemical restraints, inclusion of H atoms in calculated positions, five [Formula: see text] moieties, eleven ethanol molecules and 293 water molecules, converged with final R values of R1(Free) = 0.129 (4279 reflections) and R1 = 0.112 (85,346 reflections). The refined structure was deposited in the Protein Data Bank as structure 7p4r. Conserved waters, using four high resolution structures, have been investigated. Cluster analysis identified clusters of water molecules that are associated with the active site of Bovine Ribonuclease A. Particular attention has been paid to making detailed comparisons between the present structure and other high quality Bovine Pancreatic Ribonuclease A X-ray crystal structures with special reference to the deposited classic monoclinic structure 3RN3 Howlin et al. (Acta Crystallogr A 45:851-861, 1989). Detailed studies of various aspects of hydrogen bonding and conformation have been carried out with particular reference to active site residues Lys-1, Lys-7, Gln-11, His-12, Lys-41, Asn-44, Thr-45, Lys-66, His-119 and Ser-123. For the two histidine residues in the active site the initial electron density map gives a clear confirmation that the position of His-12 is very similar in the orthorhombic structure to that in 3RN3. In 3RN3 His-119 exhibited poor electron density which was modelled and refined as two distinct sites, A (65%) and B (35%) but with respect to His-119 in the present ultra-high resolution orthorhombic structure there is clear electron density which was modelled and refined as a single conformation distinct from either conformation A or B in 3RN3. Other points of interest include Serine-32 which is disordered at the end of the sidechain in the present orthorhombic form but has been modelled as a single form in 3RN3. Lysine-66: there is density indicating a possible conformation for this residue. However, the density is relatively weak, and the conformation is unclear. Three types of amino acid representation in the ultra-high resolution electron density are examined: (i) sharp with very clearly resolved features, for example Lys-37; (ii) well resolved but clearly divided into two conformations which are well behaved in the refinement, both having high quality geometry, for example Tyr-76; (iii) poor density and difficult or impossible to model, an example is Lys-31 for which density is missing except for Cß. The side chains of Gln-11, His-12, Lys-41, Thr-45 and His-119 are generally recognised as being closely involved in the enzyme activity. It has also been suggested that Lys-7, Asp-44, Lys-66, Phe-120, Asp-121 and Ser-123 may also have possible roles in this mechanism. A molecular dynamics study on both structures has investigated the conformations of His-119 which was modelled as two conformations in 3RN3 but is observed to have a single clearly defined conformation in the present orthorhombic structure. MD has also been used to investigate Lys-31, Lys-41 and Ser32. The form of the Ribonuclease A enzyme used in both the present study and in 3RN3 (Howlin et al. in Acta Crystallogr A 45:851-861, 1989) includes a sulphate anion which occupies approximately the same location as the [Formula: see text] phosphate group in protein nucleotide complexes (Borkakoti et al. in J Mol Biol 169:743-755, 1983). The present structure contains 5 [Formula: see text] groups SO41151-SO41155 two of which, SO41152 and SO41153 are disordered, SO41152 being in the active site, and 11 EtOH molecules, EOH A 201-EOH A 211 all of which have good geometry. H atoms were built into the EtOH molecules geometrically. Illustrations of these features in the present structure are included here. The sulphates are presumably present in the material purchased for use in the present study. 293 water molecules are included in the present structure compared to 134 in 3RN3 (Howlin et al. in Acta Crystallogr A 45:851-861, 1989).

8.
Eur J Med Chem ; 238: 114421, 2022 Aug 05.
Article in English | MEDLINE | ID: mdl-35594652

ABSTRACT

Approximately 6-7 million people around the world are estimated to be infected with Trypanosoma cruzi, the causative agent of Chagas disease. The current treatments are inadequate and therefore new medical interventions are urgently needed. In this paper we describe the identification of a series of disubstituted piperazines which shows good potency against the target parasite but is hampered by poor metabolic stability. We outline the strategies used to mitigate this issue such as lowering logD, bioisosteric replacements of the metabolically labile piperazine ring and use of plate-based arrays for quick diversity scoping. We discuss the success of these strategies within the context of this series and highlight the challenges faced in phenotypic programs when attempting to improve the pharmacokinetic profile of compounds whilst maintaining potency against the desired target.


Subject(s)
Chagas Disease , Trypanosoma cruzi , Chagas Disease/drug therapy , Chagas Disease/parasitology , Humans , Piperazines/pharmacology
9.
PLoS One ; 16(7): e0254118, 2021.
Article in English | MEDLINE | ID: mdl-34252116

ABSTRACT

Membrane proteins have a range of crucial biological functions and are the target of about 60% of all prescribed drugs. For most studies, they need to be extracted out of the lipid-bilayer, e.g. by detergent solubilisation, leading to the loss of native lipids, which may disturb important protein-lipid/bilayer interactions and thus functional and structural integrity. Relipidation of membrane proteins has proven extremely successful for studying challenging targets, but the identification of suitable lipids can be expensive and laborious. Therefore, we developed a screen to aid the high-throughput identification of beneficial lipids. The screen covers a large lipid space and was designed to be suitable for a range of stability assessment methods. Here, we demonstrate its use as a tool for identifying stabilising lipids for three membrane proteins: a bacterial pyrophosphatase (Tm-PPase), a fungal purine transporter (UapA) and a human GPCR (A2AR). A2AR is stabilised by cholesteryl hemisuccinate, a lipid well known to stabilise GPCRs, validating the approach. Additionally, our screen also identified a range of new lipids which stabilised our test proteins, providing a starting point for further investigation and demonstrating its value as a novel tool for membrane protein research. The pre-dispensed screen will be made commercially available to the scientific community in future and has a number of potential applications in the field.


Subject(s)
Detergents/chemistry , High-Throughput Screening Assays/methods , Lipids/analysis , Membrane Proteins/chemistry , Humans , Nanoparticles/chemistry , Protein Stability , Solutions
10.
J Nutr ; 140(10): 1728-35, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20685892

ABSTRACT

We previously detected a membrane-bound, copper-containing oxidase that may be involved in iron efflux in BeWo cells, a human placental cell line. We have now identified a gene encoding a predicted multicopper ferroxidase (MCF) with a putative C-terminal membrane-spanning sequence and high sequence identity to hephaestin (Heph) and ceruloplasmin (Cp), the other known vertebrate MCF. Molecular modeling revealed conservation of all type I, II, and III copper-binding sites as well as a putative iron-binding site. Protein expression was observed in multiple diverse mouse tissues, including placenta and mammary gland, and the expression pattern was distinct from that of Cp and Heph. The protein possessed ferroxidase activity, and protein levels decreased in cellular copper deficiency. Knockdown with small interfering RNA in BeWo cells indicates that this gene represents the previously detected oxidase. We propose calling this new member of the MCF family "zyklopen."


Subject(s)
Ceruloplasmin/chemistry , Ceruloplasmin/genetics , Copper/analysis , Amino Acid Sequence , Animals , Base Sequence , Binding Sites , Caco-2 Cells , Cell Line , Cell Line, Tumor , Ceruloplasmin/analysis , Copper/metabolism , Female , Gene Expression , Humans , Iron/metabolism , Mammary Glands, Animal/enzymology , Membrane Proteins/chemistry , Membrane Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Models, Molecular , Organ Specificity , Oxidoreductases Acting on CH-NH Group Donors/metabolism , Peptide Fragments/chemistry , Placenta/enzymology , Pregnancy , RNA, Small Interfering/pharmacology , Rats , Sequence Homology
11.
J Med Chem ; 63(17): 9523-9539, 2020 09 10.
Article in English | MEDLINE | ID: mdl-32663005

ABSTRACT

Visceral leishmaniasis (VL) is a parasitic infection that results in approximately 26 000-65 000 deaths annually. The available treatments are hampered by issues such as toxicity, variable efficacy, and unsuitable dosing options. The need for new treatments is urgent and led to a collaboration between the Drugs for Neglected Diseases initiative (DNDi), GlaxoSmithKline (GSK), and the University of Dundee. An 8-hydroxynaphthyridine was identified as a start point, and an early compound demonstrated weak efficacy in a mouse model of VL but was hampered by glucuronidation. Efforts to address this led to the development of compounds with improved in vitro profiles, but these were poorly tolerated in vivo. Investigation of the mode of action (MoA) demonstrated that activity was driven by sequestration of divalent metal cations, a mechanism which was likely to drive the poor tolerability. This highlights the importance of investigating MoA and pharmacokinetics at an early stage for phenotypically active series.


Subject(s)
Antiprotozoal Agents/chemistry , Antiprotozoal Agents/pharmacology , Drug Design , Leishmania/drug effects , Naphthyridines/chemistry , Naphthyridines/pharmacology , Animals , Inhibitory Concentration 50 , Mice , Solubility , Structure-Activity Relationship , Water/chemistry
12.
Nat Commun ; 10(1): 2641, 2019 06 14.
Article in English | MEDLINE | ID: mdl-31201325

ABSTRACT

Epsilon toxin (Etx), a potent pore forming toxin (PFT) produced by Clostridium perfringens, is responsible for the pathogenesis of enterotoxaemia of ruminants and has been suggested to play a role in multiple sclerosis in humans. Etx is a member of the aerolysin family of ß-PFTs (aß-PFTs). While the Etx soluble monomer structure was solved in 2004, Etx pore structure has remained elusive due to the difficulty of isolating the pore complex. Here we show the cryo-electron microscopy structure of Etx pore assembled on the membrane of susceptible cells. The pore structure explains important mutant phenotypes and suggests that the double ß-barrel, a common feature of the aß-PFTs, may be an important structural element in driving efficient pore formation. These insights provide the framework for the development of novel therapeutics to prevent human and animal infections, and are relevant for nano-biotechnology applications.


Subject(s)
Bacterial Toxins/chemistry , Clostridium perfringens/ultrastructure , Animals , Bacterial Toxins/genetics , Bacterial Toxins/isolation & purification , Bacterial Toxins/metabolism , Biotechnology/methods , Cell Line , Clostridium Infections/microbiology , Clostridium Infections/prevention & control , Clostridium perfringens/genetics , Clostridium perfringens/metabolism , Clostridium perfringens/pathogenicity , Cryoelectron Microscopy , Dogs , Enterotoxemia/microbiology , Enterotoxemia/prevention & control , Models, Molecular , Mutagenesis, Site-Directed , Nanotechnology/methods , Protein Conformation, beta-Strand/genetics , Protein Multimerization/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism
13.
ACS Med Chem Lett ; 10(3): 341-347, 2019 Mar 14.
Article in English | MEDLINE | ID: mdl-30891137

ABSTRACT

In order to study the role of S1PRs in inflammatory skin disease, S1PR modulators are dosed orally and topically in animal models of disease. The topical application of S1PR modulators in these models may, however, lead to systemic drug concentrations, which can complicate interpretation of the observed effects. We set out to design soft drug S1PR modulators as topical tool compounds to overcome this limitation. A fast follower approach starting from the drug ponesimod allowed the rapid development of an active phenolic series of soft drugs. The phenols were, however, chemically unstable. Protecting the phenol as an ester removed the instability and provided a compound that is converted by enzymatic hydrolysis in the skin to the phenolic soft drug species. In simple formulations, topical dosing of these S1PR modulators to mice led to micromolar skin concentrations but no detectable blood concentrations. These topical tools will allow researchers to investigate the role of S1PR in skin, without involvement of systemic S1PR biology.

14.
Nat Commun ; 8: 14205, 2017 02 16.
Article in English | MEDLINE | ID: mdl-28205548

ABSTRACT

Voltage-gated sodium channels (Navs) play essential roles in excitable tissues, with their activation and opening resulting in the initial phase of the action potential. The cycling of Navs through open, closed and inactivated states, and their closely choreographed relationships with the activities of other ion channels lead to exquisite control of intracellular ion concentrations in both prokaryotes and eukaryotes. Here we present the 2.45 Å resolution crystal structure of the complete NavMs prokaryotic sodium channel in a fully open conformation. A canonical activated conformation of the voltage sensor S4 helix, an open selectivity filter leading to an open activation gate at the intracellular membrane surface and the intracellular C-terminal domain are visible in the structure. It includes a heretofore unseen interaction motif between W77 of S3, the S4-S5 interdomain linker, and the C-terminus, which is associated with regulation of opening and closing of the intracellular gate.


Subject(s)
Sodium Channel Agonists/chemistry , Sodium Channel Agonists/metabolism , Voltage-Gated Sodium Channels/chemistry , Voltage-Gated Sodium Channels/physiology , Amino Acid Sequence , Electrophysiology , Ion Channel Gating/genetics , Ion Channel Gating/physiology , Ion Channels/chemistry , Ion Channels/genetics , Ion Channels/physiology , Kinetics , Models, Molecular , Mutation , Prokaryotic Cells/chemistry , Prokaryotic Cells/metabolism , Protein Conformation , Protein Domains , Protein Interaction Domains and Motifs , Sequence Alignment , Structure-Activity Relationship , Voltage-Gated Sodium Channels/genetics , X-Ray Diffraction
15.
Chem Cent J ; 11(1): 73, 2017 Aug 01.
Article in English | MEDLINE | ID: mdl-29086855

ABSTRACT

The crystal structure of a commercially available form of human recombinant (HR) insulin, Insugen (I), used in the treatment of diabetes has been determined to 0.92 Å resolution using low temperature, 100 K, synchrotron X-ray data collected at 16,000 keV (λ = 0.77 Å). Refinement carried out with anisotropic displacement parameters, removal of main-chain stereochemical restraints, inclusion of H atoms in calculated positions, and 220 water molecules, converged to a final value of R = 0.1112 and Rfree = 0.1466. The structure includes what is thought to be an ordered propanol molecule (POL) only in chain D(4) and a solvated acetate molecule (ACT) coordinated to the Zn atom only in chain B(2). Possible origins and consequences of the propanol and acetate molecules are discussed. Three types of amino acid representation in the electron density are examined in detail: (i) sharp with very clearly resolved features; (ii) well resolved but clearly divided into two conformations which are well behaved in the refinement, both having high quality geometry; (iii) poor density and difficult or impossible to model. An example of type (ii) is observed for the intra-chain disulphide bridge in chain C(3) between Sγ6-Sγ11 which has two clear conformations with relative refined occupancies of 0.8 and 0.2, respectively. In contrast the corresponding S-S bridge in chain A(1) shows one clearly defined conformation. A molecular dynamics study has provided a rational explanation of this difference between chains A and C. More generally, differences in the electron density features between corresponding residues in chains A and C and chains B and D is a common observation in the Insugen (I) structure and these effects are discussed in detail. The crystal structure, also at 0.92 Å and 100 K, of a second commercially available form of human recombinant insulin, Intergen (II), deposited in the Protein Data Bank as 3W7Y which remains otherwise unpublished is compared here with the Insugen (I) structure. In the Intergen (II) structure there is no solvated propanol or acetate molecule. The electron density of Intergen (II), however, does also exhibit the three types of amino acid representations as in Insugen (I). These effects do not necessarily correspond between chains A and C or chains B and D in Intergen (II), or between corresponding residues in Insugen (I). The results of this comparison are reported. Graphical abstract Conformations of PheB25 and PheD25 in three insulin structures: implications for biological activity? Insulin residues PheB25 and PheD25 are considered to be important for insulin receptor binding and changes in biological activity occur when these residues are modified. In porcine insulin and Intergen (II) PheB25 adopts conformation B and PheD25 conformation D. However, unexpectedly PheB25 in Insugen (I) human recombinant insulin adopts two distinct conformations corresponding to B and D, Figure 1 and PheD25 adopts a single conformation corresponding to B not D, Figure 2. Conformations of this residue in the ultra-high resolution structure of Insugen (I) are therefore unique within this set. Figures were produced with Biovia, Discovery Studio 2016.

16.
Microbiol Mol Biol Rev ; 80(3): 597-628, 2016 09.
Article in English | MEDLINE | ID: mdl-27307578

ABSTRACT

Bacterial sphingomyelinases and phospholipases are a heterogeneous group of esterases which are usually surface associated or secreted by a wide variety of Gram-positive and Gram-negative bacteria. These enzymes hydrolyze sphingomyelin and glycerophospholipids, respectively, generating products identical to the ones produced by eukaryotic enzymes which play crucial roles in distinct physiological processes, including membrane dynamics, cellular signaling, migration, growth, and death. Several bacterial sphingomyelinases and phospholipases are essential for virulence of extracellular, facultative, or obligate intracellular pathogens, as these enzymes contribute to phagosomal escape or phagosomal maturation avoidance, favoring tissue colonization, infection establishment and progression, or immune response evasion. This work presents a classification proposal for bacterial sphingomyelinases and phospholipases that considers not only their enzymatic activities but also their structural aspects. An overview of the main physiopathological activities is provided for each enzyme type, as are examples in which inactivation of a sphingomyelinase- or a phospholipase-encoding gene impairs the virulence of a pathogen. The identification of sphingomyelinases and phospholipases important for bacterial pathogenesis and the development of inhibitors for these enzymes could generate candidate vaccines and therapeutic agents, which will diminish the impacts of the associated human and animal diseases.


Subject(s)
Bacteria/pathogenicity , Fungi/pathogenicity , Phospholipase D/metabolism , Phosphoric Diester Hydrolases/metabolism , Sphingomyelin Phosphodiesterase/metabolism , Type C Phospholipases/metabolism , Bacteria/enzymology , Firmicutes/enzymology , Firmicutes/pathogenicity , Fungi/enzymology , Proteobacteria/enzymology , Proteobacteria/pathogenicity , Staphylococcus aureus/enzymology , Staphylococcus aureus/pathogenicity , Virulence Factors/metabolism
17.
Nat Commun ; 7: 11293, 2016 Apr 06.
Article in English | MEDLINE | ID: mdl-27048994

ABSTRACT

Lysenin from the coelomic fluid of the earthworm Eisenia fetida belongs to the aerolysin family of small ß-pore-forming toxins (ß-PFTs), some members of which are pathogenic to humans and animals. Despite efforts, a high-resolution structure of a channel for this family of proteins has been elusive and therefore the mechanism of activation and membrane insertion remains unclear. Here we determine the pore structure of lysenin by single particle cryo-EM, to 3.1 Å resolution. The nonameric assembly reveals a long ß-barrel channel spanning the length of the complex that, unexpectedly, includes the two pre-insertion strands flanking the hypothetical membrane-insertion loop. Examination of other members of the aerolysin family reveals high structural preservation in this region, indicating that the membrane-insertion pathway in this family is conserved. For some toxins, proteolytic activation and pro-peptide removal will facilitate unfolding of the pre-insertion strands, allowing them to form the ß-barrel of the channel.


Subject(s)
Bacterial Toxins/metabolism , Cell Membrane/metabolism , Cryoelectron Microscopy , Pore Forming Cytotoxic Proteins/metabolism , Toxins, Biological/chemistry , Humans , Lipids/chemistry , Models, Molecular , Protein Structure, Secondary , Solubility , Water/chemistry
18.
J Mol Biol ; 319(2): 275-81, 2002 May 31.
Article in English | MEDLINE | ID: mdl-12051905

ABSTRACT

Clostridium perfringens biotype A strains are the causative agents of gas-gangrene in man and are also implicated as etiological agents in sudden death syndrome in young domestic livestock. The main virulence factor produced by these strains is a zinc-dependent, phosphatidylcholine-preferring phospholipase C (alpha-toxin). The crystal structure of alpha-toxin, at pH 7.5, with the active site open and therefore accessible to substrate has previously been reported, as has calcium-binding to the C-terminal domain of the enzyme at pH 4.7. Here we focus on conformation changes in the N-terminal domain of alpha-toxin in crystals grown at acidic pH. These changes result in both the obscuring of the toxin active site and the loss of one of three zinc ions from it. Additionally, this "closed" form contains a small alpha helix, not present in the open structure, which hydrogen bonds to both the N and C-terminal domains. In conjunction with the previously reported findings that alpha-toxin can exist in active and inactive forms and that Thr74Ile and Phe69Cys substitutions markedly reduced the haemolytic activity of the enzyme, our work suggests that these loop conformations play a critical role in the activity of the toxin.


Subject(s)
Clostridium perfringens/enzymology , Type C Phospholipases/chemistry , Binding Sites , Calcium/metabolism , Crystallography, X-Ray , Hydrogen Bonding , Hydrogen-Ion Concentration , Models, Molecular , Movement , Pliability , Protein Structure, Tertiary , Type C Phospholipases/metabolism , Zinc/metabolism
19.
J Mol Biol ; 333(4): 759-69, 2003 Oct 31.
Article in English | MEDLINE | ID: mdl-14568535

ABSTRACT

Clostridium absonum phospholipase C (Caa) is a 42.7 kDa protein, which shows 60% amino acid sequence identity with the Clostridium perfringens phospholipase C, or alpha-toxin (Cpa), and has been isolated from patients suffering from gas gangrene. We report the cloning and sequencing, purification, characterisation and crystal structure of the Caa enzyme. Caa had twice the phospholipid-hydrolysing (lecithinase) activity, 1.5 times the haemolytic activity and over seven times the activity towards phosphatidylcholine-based liposomes when compared with Cpa. However, the Caa enzyme had a lower activity than Cpa to the free (i.e. not in lipid bilayer) substrate para-nitrophenylphosphorylcholine, towards sphingomyelin-based liposomes and showed half the cytotoxicity. The lethal dose (LD(50)) of Caa in mice was approximately twice that of Cpa. The crystal structure of Caa shows that the 72-93 residue loop is in a conformation different from those of previously determined open-form alpha-toxin structures. This conformational change suggests a role for W84 in membrane binding and a possible route of entry into the active site along a hydrophobic channel created by the re-arrangement of this loop. Overall, the properties of Caa are compatible with a role as a virulence-determinant in gas gangrene caused by C.absonum.


Subject(s)
Bacterial Toxins/chemistry , Bacterial Toxins/metabolism , Clostridium/enzymology , Type C Phospholipases/chemistry , Type C Phospholipases/metabolism , Amino Acid Sequence , Animals , Bacterial Toxins/genetics , Binding Sites , Crystallography, X-Ray , Mice , Models, Molecular , Molecular Sequence Data , Protein Binding , Sequence Alignment , Substrate Specificity , Type C Phospholipases/genetics
20.
J Gen Physiol ; 145(1): 5-16, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25512599

ABSTRACT

In excitable cells, the initiation of the action potential results from the opening of voltage-gated sodium channels. These channels undergo a series of conformational changes between open, closed, and inactivated states. Many models have been proposed for the structural transitions that result in these different functional states. Here, we compare the crystal structures of prokaryotic sodium channels captured in the different conformational forms and use them as the basis for examining molecular models for the activation, slow inactivation, and recovery processes. We compare structural similarities and differences in the pore domains, specifically in the transmembrane helices, the constrictions within the pore cavity, the activation gate at the cytoplasmic end of the last transmembrane helix, the C-terminal domain, and the selectivity filter. We discuss the observed differences in the context of previous models for opening, closing, and inactivation, and present a new structure-based model for the functional transitions. Our proposed prokaryotic channel activation mechanism is then compared with the activation transition in eukaryotic sodium channels.


Subject(s)
Bacterial Proteins/chemistry , Ion Channel Gating , Voltage-Gated Sodium Channels/chemistry , Amino Acid Sequence , Bacterial Proteins/metabolism , Molecular Dynamics Simulation , Molecular Sequence Data , Voltage-Gated Sodium Channels/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL